aluates Reports

$ 0.0

Automative

Swine Influenza Vaccines - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: September 2024

Report Code: QYRE-Auto-15L12249

Global Swine Influenza Vaccines Industry Research Report Growth Trends and Competitive Analysis 2022 2028

BUY CHAPTERS

Swine Influenza Vaccines - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-15L12249

Report

September 2024

Pages:123

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

ChengDu Tecbond

Green Cross Veterinary

Hipra

MSD Animal Health (Merck)

Zoetis Inc

CAHIC

Ceva

Ringpu Biology

DHN

Boehringer Ingelheim

Swine Influenza Vaccines - Market Size

The global market for Swine Influenza Vaccines was estimated to be worth US$ 124 million in 2023 and is forecast to a readjusted size of US$ 167.4 million by 2030 with a CAGR of 4.3% during the forecast period 2024-2030

Swine Influenza Vaccines - Market

Vaccines have been developed to protect against the virus that causes swine flu. There are two different brands of vaccine – Pandemrix and Celvapan.

The swine influenza vaccines market is experiencing significant growth due to the increasing prevalence of swine influenza and the rising demand for efficient disease prevention in swine populations. Swine influenza vaccines play a vital role in controlling and preventing respiratory diseases in pigs. The market is driven by factors such as the growth of the swine industry, the need for improved animal health and welfare, and the implementation of strict biosecurity measures. Advancements in vaccine development, including the availability of more effective and targeted vaccines, are further contributing to market growth. However, challenges such as the emergence of new strains of swine influenza virus and the requirement for periodic vaccine updates may impact market expansion. With the continuous focus on swine health management, disease prevention, and sustainable swine production, the swine influenza vaccines market is expected to witness sustained growth in the coming years.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Swine Influenza Vaccines, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Swine Influenza Vaccines by region & country, by Type, and by Application.

The Swine Influenza Vaccines market size, estimations, and forecasts are provided in terms of sales volume (M Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Swine Influenza Vaccines.

Market Segmentation

Scope of Swine Influenza Vaccines - Market Report

Report Metric	Details
Report Name	Swine Influenza Vaccines - Market
Forecasted market size in 2030	US$ 167.4 million
CAGR	4.3%
Forecasted years	2024 - 2030
Segment by Type:	Live Vaccines Killed Vaccines
Segment by Application	Commodity Pig Breeding Pig
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Chengdu TECBOND, Green Cross Veterinary, Hipra, MSD Animal Health (Merck), Zoetis, CAHIC, Boehringer Ingelheim, Ceva, Ringpu Biology, DHN
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Swine Influenza Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Swine Influenza Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Swine Influenza Vaccines in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Swine Influenza Vaccines - Market size in 2030?

Ans: The Swine Influenza Vaccines - Market size in 2030 will be US$ 167.4 million.

Who are the main players in the Swine Influenza Vaccines - Market report?

Ans: The main players in the Swine Influenza Vaccines - Market are Chengdu TECBOND, Green Cross Veterinary, Hipra, MSD Animal Health (Merck), Zoetis, CAHIC, Boehringer Ingelheim, Ceva, Ringpu Biology, DHN

What are the Application segmentation covered in the Swine Influenza Vaccines - Market report?

Ans: The Applications covered in the Swine Influenza Vaccines - Market report are Commodity Pig, Breeding Pig

What are the Type segmentation covered in the Swine Influenza Vaccines - Market report?

Ans: The Types covered in the Swine Influenza Vaccines - Market report are Live Vaccines, Killed Vaccines

Recommended Reports

Influenza Vaccines

Swine Related Vaccines

Respiratory & Viral Vaccines

1 Market Overview

1.1 Swine Influenza Vaccines Product Introduction

1.2 Global Swine Influenza Vaccines Market Size Forecast

1.2.1 Global Swine Influenza Vaccines Sales Value (2019-2030)

1.2.2 Global Swine Influenza Vaccines Sales Volume (2019-2030)

1.2.3 Global Swine Influenza Vaccines Sales Price (2019-2030)

1.3 Swine Influenza Vaccines Market Trends & Drivers

1.3.1 Swine Influenza Vaccines Industry Trends

1.3.2 Swine Influenza Vaccines Market Drivers & Opportunity

1.3.3 Swine Influenza Vaccines Market Challenges

1.3.4 Swine Influenza Vaccines Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Swine Influenza Vaccines Players Revenue Ranking (2023)

2.2 Global Swine Influenza Vaccines Revenue by Company (2019-2024)

2.3 Global Swine Influenza Vaccines Players Sales Volume Ranking (2023)

2.4 Global Swine Influenza Vaccines Sales Volume by Company Players (2019-2024)

2.5 Global Swine Influenza Vaccines Average Price by Company (2019-2024)

2.6 Key Manufacturers Swine Influenza Vaccines Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Swine Influenza Vaccines Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Swine Influenza Vaccines

2.9 Swine Influenza Vaccines Market Competitive Analysis

2.9.1 Swine Influenza Vaccines Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Swine Influenza Vaccines Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Swine Influenza Vaccines as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Live Vaccines

3.1.2 Killed Vaccines

3.2 Global Swine Influenza Vaccines Sales Value by Type

3.2.1 Global Swine Influenza Vaccines Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Swine Influenza Vaccines Sales Value, by Type (2019-2030)

3.2.3 Global Swine Influenza Vaccines Sales Value, by Type (%) (2019-2030)

3.3 Global Swine Influenza Vaccines Sales Volume by Type

3.3.1 Global Swine Influenza Vaccines Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Swine Influenza Vaccines Sales Volume, by Type (2019-2030)

3.3.3 Global Swine Influenza Vaccines Sales Volume, by Type (%) (2019-2030)

3.4 Global Swine Influenza Vaccines Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Commodity Pig

4.1.2 Breeding Pig

4.2 Global Swine Influenza Vaccines Sales Value by Application

4.2.1 Global Swine Influenza Vaccines Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Swine Influenza Vaccines Sales Value, by Application (2019-2030)

4.2.3 Global Swine Influenza Vaccines Sales Value, by Application (%) (2019-2030)

4.3 Global Swine Influenza Vaccines Sales Volume by Application

4.3.1 Global Swine Influenza Vaccines Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Swine Influenza Vaccines Sales Volume, by Application (2019-2030)

4.3.3 Global Swine Influenza Vaccines Sales Volume, by Application (%) (2019-2030)

4.4 Global Swine Influenza Vaccines Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Swine Influenza Vaccines Sales Value by Region

5.1.1 Global Swine Influenza Vaccines Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Swine Influenza Vaccines Sales Value by Region (2019-2024)

5.1.3 Global Swine Influenza Vaccines Sales Value by Region (2025-2030)

5.1.4 Global Swine Influenza Vaccines Sales Value by Region (%), (2019-2030)

5.2 Global Swine Influenza Vaccines Sales Volume by Region

5.2.1 Global Swine Influenza Vaccines Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Swine Influenza Vaccines Sales Volume by Region (2019-2024)

5.2.3 Global Swine Influenza Vaccines Sales Volume by Region (2025-2030)

5.2.4 Global Swine Influenza Vaccines Sales Volume by Region (%), (2019-2030)

5.3 Global Swine Influenza Vaccines Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Swine Influenza Vaccines Sales Value, 2019-2030

5.4.2 North America Swine Influenza Vaccines Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Swine Influenza Vaccines Sales Value, 2019-2030

5.5.2 Europe Swine Influenza Vaccines Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Swine Influenza Vaccines Sales Value, 2019-2030

5.6.2 Asia Pacific Swine Influenza Vaccines Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Swine Influenza Vaccines Sales Value, 2019-2030

5.7.2 South America Swine Influenza Vaccines Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Swine Influenza Vaccines Sales Value, 2019-2030

5.8.2 Middle East & Africa Swine Influenza Vaccines Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Swine Influenza Vaccines Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Swine Influenza Vaccines Sales Value

6.2.1 Key Countries/Regions Swine Influenza Vaccines Sales Value, 2019-2030

6.2.2 Key Countries/Regions Swine Influenza Vaccines Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Swine Influenza Vaccines Sales Value, 2019-2030

6.3.2 United States Swine Influenza Vaccines Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Swine Influenza Vaccines Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Swine Influenza Vaccines Sales Value, 2019-2030

6.4.2 Europe Swine Influenza Vaccines Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Swine Influenza Vaccines Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Swine Influenza Vaccines Sales Value, 2019-2030

6.5.2 China Swine Influenza Vaccines Sales Value by Type (%), 2023 VS 2030

6.5.3 China Swine Influenza Vaccines Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Swine Influenza Vaccines Sales Value, 2019-2030

6.6.2 Japan Swine Influenza Vaccines Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Swine Influenza Vaccines Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Swine Influenza Vaccines Sales Value, 2019-2030

6.7.2 South Korea Swine Influenza Vaccines Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Swine Influenza Vaccines Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Swine Influenza Vaccines Sales Value, 2019-2030

6.8.2 Southeast Asia Swine Influenza Vaccines Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Swine Influenza Vaccines Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Swine Influenza Vaccines Sales Value, 2019-2030

6.9.2 India Swine Influenza Vaccines Sales Value by Type (%), 2023 VS 2030

6.9.3 India Swine Influenza Vaccines Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Chengdu TECBOND

7.1.1 Chengdu TECBOND Company Information

7.1.2 Chengdu TECBOND Introduction and Business Overview

7.1.3 Chengdu TECBOND Swine Influenza Vaccines Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Chengdu TECBOND Swine Influenza Vaccines Product Offerings

7.1.5 Chengdu TECBOND Recent Development

7.2 Green Cross Veterinary

7.2.1 Green Cross Veterinary Company Information

7.2.2 Green Cross Veterinary Introduction and Business Overview

7.2.3 Green Cross Veterinary Swine Influenza Vaccines Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Green Cross Veterinary Swine Influenza Vaccines Product Offerings

7.2.5 Green Cross Veterinary Recent Development

7.3 Hipra

7.3.1 Hipra Company Information

7.3.2 Hipra Introduction and Business Overview

7.3.3 Hipra Swine Influenza Vaccines Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Hipra Swine Influenza Vaccines Product Offerings

7.3.5 Hipra Recent Development

7.4 MSD Animal Health (Merck)

7.4.1 MSD Animal Health (Merck) Company Information

7.4.2 MSD Animal Health (Merck) Introduction and Business Overview

7.4.3 MSD Animal Health (Merck) Swine Influenza Vaccines Sales, Revenue and Gross Margin (2019-2024)

7.4.4 MSD Animal Health (Merck) Swine Influenza Vaccines Product Offerings

7.4.5 MSD Animal Health (Merck) Recent Development

7.5 Zoetis

7.5.1 Zoetis Company Information

7.5.2 Zoetis Introduction and Business Overview

7.5.3 Zoetis Swine Influenza Vaccines Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Zoetis Swine Influenza Vaccines Product Offerings

7.5.5 Zoetis Recent Development

7.6 CAHIC

7.6.1 CAHIC Company Information

7.6.2 CAHIC Introduction and Business Overview

7.6.3 CAHIC Swine Influenza Vaccines Sales, Revenue and Gross Margin (2019-2024)

7.6.4 CAHIC Swine Influenza Vaccines Product Offerings

7.6.5 CAHIC Recent Development

7.7 Boehringer Ingelheim

7.7.1 Boehringer Ingelheim Company Information

7.7.2 Boehringer Ingelheim Introduction and Business Overview

7.7.3 Boehringer Ingelheim Swine Influenza Vaccines Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Boehringer Ingelheim Swine Influenza Vaccines Product Offerings

7.7.5 Boehringer Ingelheim Recent Development

7.8 Ceva

7.8.1 Ceva Company Information

7.8.2 Ceva Introduction and Business Overview

7.8.3 Ceva Swine Influenza Vaccines Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Ceva Swine Influenza Vaccines Product Offerings

7.8.5 Ceva Recent Development

7.9 Ringpu Biology

7.9.1 Ringpu Biology Company Information

7.9.2 Ringpu Biology Introduction and Business Overview

7.9.3 Ringpu Biology Swine Influenza Vaccines Sales, Revenue and Gross Margin (2019-2024)

7.9.4 Ringpu Biology Swine Influenza Vaccines Product Offerings

7.9.5 Ringpu Biology Recent Development

7.10 DHN

7.10.1 DHN Company Information

7.10.2 DHN Introduction and Business Overview

7.10.3 DHN Swine Influenza Vaccines Sales, Revenue and Gross Margin (2019-2024)

7.10.4 DHN Swine Influenza Vaccines Product Offerings

7.10.5 DHN Recent Development

8 Industry Chain Analysis

8.1 Swine Influenza Vaccines Industrial Chain

8.2 Swine Influenza Vaccines Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Swine Influenza Vaccines Sales Model

8.5.2 Sales Channel

8.5.3 Swine Influenza Vaccines Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

ChengDu Tecbond

Green Cross Veterinary

Hipra

MSD Animal Health (Merck)

Zoetis Inc

CAHIC

Ceva

Ringpu Biology

DHN

Boehringer Ingelheim

List of Tables

Table 1. Swine Influenza Vaccines Market Trends

Table 2. Swine Influenza Vaccines Market Drivers & Opportunity

Table 3. Swine Influenza Vaccines Market Challenges

Table 4. Swine Influenza Vaccines Market Restraints

Table 5. Global Swine Influenza Vaccines Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Swine Influenza Vaccines Revenue Market Share by Company (2019-2024)

Table 7. Global Swine Influenza Vaccines Sales Volume by Company (2019-2024) & (M Units)

Table 8. Global Swine Influenza Vaccines Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Swine Influenza Vaccines Price by Company (2019-2024) & (USD/K Unit)

Table 10. Key Manufacturers Swine Influenza Vaccines Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Swine Influenza Vaccines Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Swine Influenza Vaccines

Table 13. Global Swine Influenza Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Swine Influenza Vaccines as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Swine Influenza Vaccines Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Swine Influenza Vaccines Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Swine Influenza Vaccines Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Swine Influenza Vaccines Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Swine Influenza Vaccines Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Swine Influenza Vaccines Sales Volume by Type: 2019 VS 2023 VS 2030 (M Units)

Table 22. Global Swine Influenza Vaccines Sales Volume by Type (2019-2024) & (M Units)

Table 23. Global Swine Influenza Vaccines Sales Volume by Type (2025-2030) & (M Units)

Table 24. Global Swine Influenza Vaccines Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Swine Influenza Vaccines Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Swine Influenza Vaccines Price by Type (2019-2024) & (USD/K Unit)

Table 27. Global Swine Influenza Vaccines Price by Type (2025-2030) & (USD/K Unit)

Table 28. Global Swine Influenza Vaccines Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Swine Influenza Vaccines Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Swine Influenza Vaccines Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Swine Influenza Vaccines Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Swine Influenza Vaccines Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Swine Influenza Vaccines Sales Volume by Application: 2019 VS 2023 VS 2030 (M Units)

Table 34. Global Swine Influenza Vaccines Sales Volume by Application (2019-2024) & (M Units)

Table 35. Global Swine Influenza Vaccines Sales Volume by Application (2025-2030) & (M Units)

Table 36. Global Swine Influenza Vaccines Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Swine Influenza Vaccines Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Swine Influenza Vaccines Price by Application (2019-2024) & (USD/K Unit)

Table 39. Global Swine Influenza Vaccines Price by Application (2025-2030) & (USD/K Unit)

Table 40. Global Swine Influenza Vaccines Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Swine Influenza Vaccines Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Swine Influenza Vaccines Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Swine Influenza Vaccines Sales Value by Region (2019-2024) & (%)

Table 44. Global Swine Influenza Vaccines Sales Value by Region (2025-2030) & (%)

Table 45. Global Swine Influenza Vaccines Sales Volume by Region (M Units): 2019 VS 2023 VS 2030

Table 46. Global Swine Influenza Vaccines Sales Volume by Region (2019-2024) & (M Units)

Table 47. Global Swine Influenza Vaccines Sales Volume by Region (2025-2030) & (M Units)

Table 48. Global Swine Influenza Vaccines Sales Volume by Region (2019-2024) & (%)

Table 49. Global Swine Influenza Vaccines Sales Volume by Region (2025-2030) & (%)

Table 50. Global Swine Influenza Vaccines Average Price by Region (2019-2024) & (USD/K Unit)

Table 51. Global Swine Influenza Vaccines Average Price by Region (2025-2030) & (USD/K Unit)

Table 52. Key Countries/Regions Swine Influenza Vaccines Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Swine Influenza Vaccines Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Swine Influenza Vaccines Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Swine Influenza Vaccines Sales Volume, (2019-2024) & (M Units)

Table 56. Key Countries/Regions Swine Influenza Vaccines Sales Volume, (2025-2030) & (M Units)

Table 57. Chengdu TECBOND Company Information

Table 58. Chengdu TECBOND Introduction and Business Overview

Table 59. Chengdu TECBOND Swine Influenza Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2019-2024)

Table 60. Chengdu TECBOND Swine Influenza Vaccines Product Offerings

Table 61. Chengdu TECBOND Recent Development

Table 62. Green Cross Veterinary Company Information

Table 63. Green Cross Veterinary Introduction and Business Overview

Table 64. Green Cross Veterinary Swine Influenza Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2019-2024)

Table 65. Green Cross Veterinary Swine Influenza Vaccines Product Offerings

Table 66. Green Cross Veterinary Recent Development

Table 67. Hipra Company Information

Table 68. Hipra Introduction and Business Overview

Table 69. Hipra Swine Influenza Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2019-2024)

Table 70. Hipra Swine Influenza Vaccines Product Offerings

Table 71. Hipra Recent Development

Table 72. MSD Animal Health (Merck) Company Information

Table 73. MSD Animal Health (Merck) Introduction and Business Overview

Table 74. MSD Animal Health (Merck) Swine Influenza Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2019-2024)

Table 75. MSD Animal Health (Merck) Swine Influenza Vaccines Product Offerings

Table 76. MSD Animal Health (Merck) Recent Development

Table 77. Zoetis Company Information

Table 78. Zoetis Introduction and Business Overview

Table 79. Zoetis Swine Influenza Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2019-2024)

Table 80. Zoetis Swine Influenza Vaccines Product Offerings

Table 81. Zoetis Recent Development

Table 82. CAHIC Company Information

Table 83. CAHIC Introduction and Business Overview

Table 84. CAHIC Swine Influenza Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2019-2024)

Table 85. CAHIC Swine Influenza Vaccines Product Offerings

Table 86. CAHIC Recent Development

Table 87. Boehringer Ingelheim Company Information

Table 88. Boehringer Ingelheim Introduction and Business Overview

Table 89. Boehringer Ingelheim Swine Influenza Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2019-2024)

Table 90. Boehringer Ingelheim Swine Influenza Vaccines Product Offerings

Table 91. Boehringer Ingelheim Recent Development

Table 92. Ceva Company Information

Table 93. Ceva Introduction and Business Overview

Table 94. Ceva Swine Influenza Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2019-2024)

Table 95. Ceva Swine Influenza Vaccines Product Offerings

Table 96. Ceva Recent Development

Table 97. Ringpu Biology Company Information

Table 98. Ringpu Biology Introduction and Business Overview

Table 99. Ringpu Biology Swine Influenza Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2019-2024)

Table 100. Ringpu Biology Swine Influenza Vaccines Product Offerings

Table 101. Ringpu Biology Recent Development

Table 102. DHN Company Information

Table 103. DHN Introduction and Business Overview

Table 104. DHN Swine Influenza Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2019-2024)

Table 105. DHN Swine Influenza Vaccines Product Offerings

Table 106. DHN Recent Development

Table 107. Key Raw Materials Lists

Table 108. Raw Materials Key Suppliers Lists

Table 109. Swine Influenza Vaccines Downstream Customers

Table 110. Swine Influenza Vaccines Distributors List

Table 111. Research Programs/Design for This Report

Table 112. Key Data Information from Secondary Sources

Table 113. Key Data Information from Primary Sources

List of Figures

Figure 1. Swine Influenza Vaccines Product Picture

Figure 2. Global Swine Influenza Vaccines Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Swine Influenza Vaccines Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Swine Influenza Vaccines Sales Volume (2019-2030) & (M Units)

Figure 5. Global Swine Influenza Vaccines Sales Price (2019-2030) & (USD/K Unit)

Figure 6. Swine Influenza Vaccines Report Years Considered

Figure 7. Global Swine Influenza Vaccines Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Swine Influenza Vaccines Players Sales Volume Ranking (2023) & (M Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Swine Influenza Vaccines Revenue in 2023

Figure 10. Swine Influenza Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Live Vaccines Picture

Figure 12. Killed Vaccines Picture

Figure 13. Global Swine Influenza Vaccines Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global Swine Influenza Vaccines Sales Value Market Share by Type, 2023 & 2030

Figure 15. Global Swine Influenza Vaccines Sales Volume by Type (2019 VS 2023 VS 2030) & (M Units)

Figure 16. Global Swine Influenza Vaccines Sales Volume Market Share by Type, 2023 & 2030

Figure 17. Global Swine Influenza Vaccines Price by Type (2019-2030) & (USD/K Unit)

Figure 18. Product Picture of Commodity Pig

Figure 19. Product Picture of Breeding Pig

Figure 20. Global Swine Influenza Vaccines Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 21. Global Swine Influenza Vaccines Sales Value Market Share by Application, 2023 & 2030

Figure 22. Global Swine Influenza Vaccines Sales Volume by Application (2019 VS 2023 VS 2030) & (M Units)

Figure 23. Global Swine Influenza Vaccines Sales Volume Market Share by Application, 2023 & 2030

Figure 24. Global Swine Influenza Vaccines Price by Application (2019-2030) & (USD/K Unit)

Figure 25. North America Swine Influenza Vaccines Sales Value (2019-2030) & (US$ Million)

Figure 26. North America Swine Influenza Vaccines Sales Value by Country (%), 2023 VS 2030

Figure 27. Europe Swine Influenza Vaccines Sales Value (2019-2030) & (US$ Million)

Figure 28. Europe Swine Influenza Vaccines Sales Value by Country (%), 2023 VS 2030

Figure 29. Asia Pacific Swine Influenza Vaccines Sales Value (2019-2030) & (US$ Million)

Figure 30. Asia Pacific Swine Influenza Vaccines Sales Value by Country (%), 2023 VS 2030

Figure 31. South America Swine Influenza Vaccines Sales Value (2019-2030) & (US$ Million)

Figure 32. South America Swine Influenza Vaccines Sales Value by Country (%), 2023 VS 2030

Figure 33. Middle East & Africa Swine Influenza Vaccines Sales Value (2019-2030) & (US$ Million)

Figure 34. Middle East & Africa Swine Influenza Vaccines Sales Value by Country (%), 2023 VS 2030

Figure 35. Key Countries/Regions Swine Influenza Vaccines Sales Value (%), (2019-2030)

Figure 36. Key Countries/Regions Swine Influenza Vaccines Sales Volume (%), (2019-2030)

Figure 37. United States Swine Influenza Vaccines Sales Value, (2019-2030) & (US$ Million)

Figure 38. United States Swine Influenza Vaccines Sales Value by Type (%), 2023 VS 2030

Figure 39. United States Swine Influenza Vaccines Sales Value by Application (%), 2023 VS 2030

Figure 40. Europe Swine Influenza Vaccines Sales Value, (2019-2030) & (US$ Million)

Figure 41. Europe Swine Influenza Vaccines Sales Value by Type (%), 2023 VS 2030

Figure 42. Europe Swine Influenza Vaccines Sales Value by Application (%), 2023 VS 2030

Figure 43. China Swine Influenza Vaccines Sales Value, (2019-2030) & (US$ Million)

Figure 44. China Swine Influenza Vaccines Sales Value by Type (%), 2023 VS 2030

Figure 45. China Swine Influenza Vaccines Sales Value by Application (%), 2023 VS 2030

Figure 46. Japan Swine Influenza Vaccines Sales Value, (2019-2030) & (US$ Million)

Figure 47. Japan Swine Influenza Vaccines Sales Value by Type (%), 2023 VS 2030

Figure 48. Japan Swine Influenza Vaccines Sales Value by Application (%), 2023 VS 2030

Figure 49. South Korea Swine Influenza Vaccines Sales Value, (2019-2030) & (US$ Million)

Figure 50. South Korea Swine Influenza Vaccines Sales Value by Type (%), 2023 VS 2030

Figure 51. South Korea Swine Influenza Vaccines Sales Value by Application (%), 2023 VS 2030

Figure 52. Southeast Asia Swine Influenza Vaccines Sales Value, (2019-2030) & (US$ Million)

Figure 53. Southeast Asia Swine Influenza Vaccines Sales Value by Type (%), 2023 VS 2030

Figure 54. Southeast Asia Swine Influenza Vaccines Sales Value by Application (%), 2023 VS 2030

Figure 55. India Swine Influenza Vaccines Sales Value, (2019-2030) & (US$ Million)

Figure 56. India Swine Influenza Vaccines Sales Value by Type (%), 2023 VS 2030

Figure 57. India Swine Influenza Vaccines Sales Value by Application (%), 2023 VS 2030

Figure 58. Swine Influenza Vaccines Industrial Chain

Figure 59. Swine Influenza Vaccines Manufacturing Cost Structure

Figure 60. Channels of Distribution (Direct Sales, and Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Swine Flu Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Influenza Virus Vaccine H1N1 Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Pandemic Influenza Vaccine Market Research Report 2025

Swine Mycoplasma Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Porcine Medicine and Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Swine Epidemic Diarrhea Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Flu RNA Vaccines Market Research Report 2025

Global Vaccine for Influenza Market Research Report 2025

Poliovirus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Mycoplasma Hyopneumoniae Vaccine Market Research Report 2024

Inactivated Vaccine for Swine Mycoplasma Pneumonia Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Swine Circovirus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Swine Parvovirus Disease Vaccine Market Research Report 2024

Porcine Epidemic Diarrhea Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Flu Vaccine Market Insights Forecast to 2030

Global Swine Fever Vaccine Market Insights Forecast to 2030

Global Waterfowl Vaccines Market Research Report 2024

Hog Cholera Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Swine Streptococcus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions